Numerous types of cancer have been shown to be associated with either ischemic or
hemorrhagic stroke. In this review, the epidemiology and pathophysiology of stroke in …

Currently 1 in 10 patients with ischemic stroke have comorbid cancer, and this frequency is
expected to increase with continued advances in cancer therapeutics prolonging median …

Abstract Purpose of Review To review the latest information about the interactions between
cancer and cerebrovascular disease. Recent Findings Additional data support the finding …

Cancer-related stroke (CRS), referring to ischemic stroke occurring in cancer patients
without other clear etiology, represents a clinical challenge, as it is associated with …

The efficacy and safety of intravenous thrombolysis (IVT) for acute ischemic stroke (AIS) in
cancer patients remained uncertain due to low level evidence in the latest guideline for AIS …

Intracranial tumors pose a challenge in neurosurgery, especially when patients present
emergently or require emergency surgery. Tackling an acute change in the patient's mental …

Abstract Purpose of Review This article reviews the risk factors, clinical presentations,
differential diagnosis, and the types of strokes frequently seen in patients with primary brain …

Introduction: Intravenous tissue-plasminogen activator (tPA) remains the only approved
systemic reperfusion therapy suitable for most patients presenting timely with acute ischemic …

To date, very few studies focused their attention on efficacy and safety of recanalisation
therapy in acute ischemic stroke (AIS) patients with cancer, reporting conflicting results. We …

Background Single-center studies suggest that patients with cancer have similar outcomes
after intracerebral hemorrhage (ICH) compared to patients without cancer. However, these …